Perspective Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

CATX
Perspective Therapeutics

Last Price:

3.35

Seasonality Move:

40.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Perspective Therapeutics Stock Forecast

Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 21.9% based on the past 20 years of stock performance.
Perspective Therapeutics has risen higher in 7 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 35%
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 21.9% based on the past 20 years of stock performance.

Perspective Therapeutics Stock Rating

Sell

Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics overpriced?

Perspective Therapeutics has risen higher in 7 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 35%

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NYAM

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

perspectivetherapeutics.com

52-Week Data

52-Week High:

19.05

52-Week Low:

2.28

Prediction Charts

Market Cap:

417.01M

Price in USD:

6.17

Volume:

1.16M

Beta:

1.34

Technical Analysis

SMA50:

12.08

SMA100:

12.67

SMA200:

12.78

52-Wk Change:

149.6%

Stock Predictions

Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company.
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 6.17 USD today.
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-1	11.97	12.09	12.21	11.64
Nov-4	12.09	12.19	12.90	11.79
Nov-5	12.15	12.34	12.39	11.95
Nov-6	12.51	12.34	12.82	12.18
Nov-7	12.26	11.78	12.42	11.67
Nov-8	11.71	11.25	11.83	11.13
Nov-11	11.58	11.09	11.69	11.03
Nov-12	11.17	10.67	11.17	10.51
Nov-13	10.55	9.93	10.77	9.85
Nov-14	10.06	8.92	10.06	8.86
Nov-15	8.92	7.88	8.93	7.87
Nov-18	7.95	6.96	7.95	6.79
Nov-19	6.69	6.78	7.08	6.55
Nov-20	6.87	6.17	6.87	6.01

Perspective Therapeutics Earnings

Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Perspective Therapeutics Forecast Revenue Growth

Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.